AkramN, ImranM, NoreenM, et al.Oncogenic role of tumor viruses in humans. Viral Immunol, 2016; 30:20–27.
2.
AnohAE, MossounA, Akoua-KoffiC, et al.Seroprevalence of cytomegalovirus infection among a rural population of Cote d'Ivoire. Viral Immunol, 2016; 30:54–57.
3.
ArciaD, Acevedo-SaenzL, RugelesMT, et al.Role of CD8+ T cells in the selection of HIV-1 immune escape mutations. Viral Immunol, 2016; 30:3–12.
4.
Bender IgnacioRA, RamchandaniMS, LaingKJ, et al.T cell immunity to varicella-zoster virus in the setting of advanced HIV and multiple varicella-zoster virus recurrences. Viral Immunol, 2016; 30:77–80.
5.
Del Medico ZajacM, ZanettiFA, EsusyMS, et al.Induction of both local immune response in mice and protection in a rabbit model by intranasal immunization with modified vaccinia Ankara virus expressing a secreted form of bovine herpesvirus 1 glycoprotein D. Viral Immunol, 2016; 30:70–76.
6.
DhamanageA, ThakarM, and ParanjapeR. Human immunodeficiency virus-1 impairs IFN-alpha production induced by TLR-7 agonist in plasmacytoid dendritic cells. Viral Immunol, 2016; 30:28–34.
7.
LuB, ZhangB, WangL, et al.Hepatitis B virus e antigen regulates monocyte function and promotes B lymphocyte activation. Viral Immunol, 2016; 30:35–44.
8.
Perdomo-CelisF, SalgadoDM, and NarvaezCF. Levels of circulating tumor necrosis factor-a in children with symptomatic dengue evaluated by ELISA and bead-based assays. Viral Immunol, 2016; 30:45–53.
9.
PostJ, WeesendropE, MontoyaM, et al.Influence of age and dose of African swine fever virus infections on clinical outcome and blood parameters in pigs. Viral Immunol, 2016; 30:58–69.
10.
SuwanmaneeS, and LuplertlopN. Immunopathogenesis of dengue virus-induced redundant cell death: Apoptosis and pyroptosis. Viral Immunol, 2016; 30:13–19.
